Paper Details
- Home
- Paper Details
Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.
Author: AvisHans J, BraamskampMarjet J A M, HuttenBarbara A, KasteleinJohn J P, KustersD Meeike, SmetsEllen M A, WiegmanAlbert, WijburgFrits A
Original Abstract of the Article :
BACKGROUND: Statins are currently the preferred pharmacological therapy in individuals with familial hypercholesterolemia (FH) with the aim to prevent premature atherosclerosis. In adults, these agents have been proven to be safe and well tolerated; however, non-adherence is a significant clinical i...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372689/
データ提供:米国国立医学図書館(NLM)
Long-Term Statin Therapy: Assessing Tolerability and Adherence in Familial Hypercholesterolemia
The field of [cardiology] is dedicated to preventing and treating [heart disease]. This research focuses on the long-term use of [statin therapy] in individuals with [familial hypercholesterolemia (FH)], a genetic condition characterized by high cholesterol levels. The study aimed to evaluate the tolerability and adherence to statin therapy in young adult FH patients who had initiated treatment in childhood.
Statin Therapy: Demonstrating Long-Term Safety and Good Adherence
The study found that [statin therapy] was well-tolerated and resulted in good adherence rates in young adult FH patients who had initiated treatment in childhood. The majority of patients remained on statin therapy for at least 10 years, with a minimal number discontinuing due to side effects. The findings highlight the potential for long-term benefits of statin therapy in reducing cardiovascular risks associated with FH.
Managing Cholesterol: A Lifelong Commitment
This research underscores the importance of maintaining a lifelong commitment to managing cholesterol levels, particularly in individuals with FH. The study's findings support the use of statin therapy as a safe and effective long-term treatment option for reducing cardiovascular risks. It's essential to consult with your healthcare provider to discuss your individual risk factors, treatment options, and any concerns you may have about statin therapy.
Dr.Camel's Conclusion
This study is like a camel traversing a vast desert, where statin therapy acts as a reliable guide to help navigate the journey of managing cholesterol levels. The research confirms the long-term safety and good adherence to statin therapy in FH patients, highlighting its potential for reducing cardiovascular risks and improving long-term health outcomes.
Date :
- Date Completed 2015-08-11
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.